CPLD 2005 FFTri vs Respondent M50

Facts
The French Triathlon Federation (Fédération Française de Triathlon, FFTri) charges respondent M50 for a violation of the Anti-Doping Rules. During a match on March 20, 2005, a sample was taken for doping tests purposes. The analysis of the sample showed the presence of metabolites of nandrolone and ephedrine which are prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent was sanctioned by the disciplinary committee of the FFTri with a period of ineligibility of two years extended to the French Swimming Federation, French Athletics Federation and the French Cycling Federation. Respondent appealed against this decision but the appeal committee of the FFTri confirmed the given sanction.
However the respondent didn't produce any new information towards this case before the board. Regarding the seriousness the sanction will be extended to all sport federations.

Decision
1. The sanction is a period of ineligibility of two years in which respondent can't take part in competition or manifestations organized or authorized by French sport federations.
2. The decision starts on the date of notification and ends as sanctioned by the appeal committee of the FFTri.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
8 December 2005
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Aggravating circumstances
Sport/IFs
Triathlon (TRI) - World Triathlon
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Conseil de Prévention et de Lutte contre le Dopage (CPLD) - Council to Prevent and Counteract Doping
Fédération Française de Triathlon (FFTri) - French Triathlon Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
S6. Stimulants
Substances
Ephedrine
Nandrolone (19-nortestosterone)
Document type
Pdf file
Date generated
5 December 2014
Date of last modification
22 June 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin